Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

DNA vaccines

J J Donnelly¹, J B Ulmer, M A Liu

¹Department of Virus and Cell Biology, Merck Research Laboratories, West Point, PA, USA.

Developments in Biological Standardization

|December 17, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DNA vaccines.

Methods in molecular medicine·2011

Same author

A Modified ELISA for Measurement of High-Avidity IgG Antibodies to Meningococcal Serogroup C Polysaccharide that Correlate with Bactericidal Titers.

Methods in molecular medicine·2011

Same author

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Vaccine·2010

Same author

Public health. The cholera crisis in Africa.

Science (New York, N.Y.)·2009

Same author

Topic in Review: Vaccines in the 21st century.

The Western journal of medicine·2008

Same author

Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer.

Scandinavian journal of immunology·2007

Same journal

International challenges and public policy issues.

Developments in biological standardization·2000

Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000

Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000

Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000

Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000

Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000

See all related articles

DNA vaccination, using plasmid DNA to encode antigens, effectively induces both antibody and cell-mediated immunity. This approach offers a promising method for developing vaccines against various pathogens and screening for protective antigens.

Area of Science:

Immunology
Vaccinology
Molecular Biology

Background:

Plasmid DNA encoding antigenic proteins can elicit robust immune responses.
This DNA immunization technique allows for in vivo production of antigens, preserving their native structure.

Purpose of the Study:

To evaluate the efficacy of DNA immunization in inducing protective immunity.
To explore DNA vaccination as a method for antigen screening and pathogen control.

Main Methods:

Immunization of animal models with plasmid DNA encoding specific antigenic proteins.
Assessment of both antibody and cell-mediated immune responses post-vaccination.

Main Results:

DNA immunization successfully induced protective immunity in various animal models.

Related Experiment Videos

The immune responses generated were comparable or superior to conventional immunization methods.

This method facilitates the induction of conformationally specific antibodies and cellular immunity.

Conclusions:

DNA vaccination is a versatile and effective strategy for inducing protective immunity against diverse pathogens.
It serves as a valuable tool for rapid antigen screening and development of novel vaccines.
The approach holds significant potential for addressing clinical infectious diseases.